Brief: Hungary's Richter receives European Commission approval for Fylrevy
27/03/2026 09:09
March 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: IT RECEIVES EUROPEAN COMMISSION APPROVAL FOR THE MARKETING AUTHORIZATION OF FYLREVY (ESTETROL TABLET, DEVELOPED UNDER THE NAME DONESTA) IT RECEIVES APPROVAL FOR FYLREVY AS HORMONE REPLACEMENT THREAPY FOR OESTROGEN DEFICIENCY SYMPTOMS IN POSTMENOPAUSAL WOMEN DECISION IS APPLICABLE FOR ALL MEMBER STATES OF THE EUROPEAN ECONOMIC AREA Source text: [https://www.bse.hu/newkibdata/129423361/Fylrevy_EC%20approval_Mar2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab